Senior insider sale
Chief Technical Ops Officer at PTC THERAPEUTICS, INC. — senior position signals high conviction
$9.32M
113.91K shares
ALMSTEAD NEIL GREGORY plans to sell 113.91K shares of PTC THERAPEUTICS, INC. valued at approximately $9.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Restricted Stock Vesting Compensation | 3.06K | — |
| Total | 3.06K | ||
Completed
Units to sell
59.00
Market value
$4.5K
Units to sell
881.00
Market value
$67.4K
Units to sell
1.03K
Market value
$79.5K
Units to sell
52.00
Market value
$4.0K
Units to sell
54.00
Market value
$4.2K
Units to sell
1.28K
Market value
$98.4K
Units to sell
71.93K
Market value
$6.00M
Units to sell
35.57K
Market value
$2.85M
Planned — Approximate Date
Units to sell
3.06K
Market value
$212.0K
Units
113.91K
Value
$9.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/8/2026 | 59.00 | $4.5K | — | Completed |
1/8/2026 | 881.00 | $67.4K | — | Completed |
1/7/2026 | 1.03K | $79.5K | — | Completed |
1/7/2026 | 52.00 | $4.0K | — | Completed |
1/6/2026 | 54.00 | $4.2K | — | Completed |
1/6/2026 | 1.28K | $98.4K | — | Completed |
11/25/2025 | 71.93K | $6.00M | — | Completed |
11/24/2025 | 35.57K | $2.85M | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 3.06K | $212.0K | NASDAQ | Planned |
| Total | 113.91K | $9.32M | ||